4.7 Review

E3 ubiquitin ligases as novel targets for inflammatory diseases

Journal

PHARMACOLOGICAL RESEARCH
Volume 106, Issue -, Pages 1-9

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2016.02.006

Keywords

Inflammation; Ubiquitination; E3 ubiquitin ligase; Metabolic disorders; Asthma; Cardiac inflammation

Funding

  1. Council of Scientific and Industrial Research (CSIR), Government of India [37(1644)/15/EMR-II]

Ask authors/readers for more resources

Ubiquitination is one of the post translational modifications which decide the fate of various proteins in the cells, by either directing them towards proteasomal degradation or participation in several cell signalling pathways. Recently, the role of ubiquitination has been unravelled in pathogenesis and progression of various diseases, where inflammation is critical, like obesity, insulin resistance, atherosclerosis, angiotensin-II induced cardiac inflammation and asthma. E3 ligases are known to be instrumental in regulation of the inflammatory cascade. This review focuses on the role of different E3 ligases in the development of inflammatory diseases and thus may help us to target these E3 ligases in future drug discovery to prevent inflammation. (C) 2016 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available